Teva Pharmaceutical Industries Ltd.
FDA inspection history in Kfar Saba, Israel, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at Kfar Saba, Israel.
Cited most
Across all Teva Pharmaceutical Industries observations on file
- 21 CFR 211.67(a)Equipment cleaning and maintenance2
- 21 CFR 211.113(b)Control of microbiological contamination1
- 21 CFR 211.192Production record review1
- 21 CFR 211.42(c)(10)(iv)Design and construction features1
The complete Teva Pharmaceutical Industries file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Kfar Saba, Israel
One Form 483 · 2023 · 5 observations
Latest: Form 483, May 23, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-05-23 | 483 Form 483 | Kfar Saba, Israel | 5 | $99 |
Investigators on these documents
FEI number 3002721084 · most recent document May 23, 2023
About Teva Pharmaceutical Industries Ltd.
How many FDA Form 483s has Teva Pharmaceutical Industries Ltd. received?
FDA Intel has 1 Form 483 on file for Teva Pharmaceutical Industries Ltd.; the most recent is dated May 23, 2023.
When was Teva Pharmaceutical Industries Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Teva Pharmaceutical Industries Ltd. is a Form 483 dated May 23, 2023, for the site in Kfar Saba, Israel.
What did FDA cite at Teva Pharmaceutical Industries Ltd.?
The regulations cited most in the observations on file for Teva Pharmaceutical Industries Ltd. are 21 CFR 211.67(a) (Equipment cleaning and maintenance), 2 times; 21 CFR 211.113(b) (Control of microbiological contamination), 1 time; 21 CFR 211.192 (Production record review), 1 time.